Speaking at a press conference on Tuesday, Head of the Syndicate of Iranian Holders of Human Pharmaceutical Industries Abbas Kebriyayizade said Iran and Russia are developing cooperation in the pharmaceutical industry.
As part of that interaction, 3 medicines with Iranian formula will be jointly produced in Russia, he added.
His comments came after major Iranian and Russian pharmaceutical manufacturers signed an agreement in March to localize production of an influenza vaccine in Iran.
According to the deal, Iran’s Sobhan Recombinant Protein firm and Russia’s Petrovax company will jointly produce the Russian-developed 'Grippol Plus' flu vaccine in Iran.
The 'Grippol Plus' vaccine is given to children and pregnant women to prevent them falling ill with flu, and is sold throughout the Commonwealth of Independent States and in some EU countries.